StemCell Institute Company Description

StemCell Institute Inc. engages in the stem cell banking business in Japan.

The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses.

StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.

StemCell Institute Inc.

Country	Japan
Founded	1999
Industry	Biotechnology
Sector	Healthcare
Employees	98
CEO	Takafumi Shimizu

Contact Details

Address: 1-21-19, Toranomon Tokyo, 105-0001 Japan
Phone	81 3 6811 3230
Website	stemcell.co.jp

Stock Details

Ticker Symbol	7096
Exchange	Tokyo Stock Exchange
Stock Type	Common Stock
Fiscal Year	April - March
Reporting Currency	JPY
ISIN Number	JP3399640006
SIC Code	8090

Key Executives

Name	Position
Takafumi Shimizu	Chief Executive Officer